Cheng-kun Yang

Shuang Yong Rd. 6#
Nanning, 530021, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Diagnostic value of alpha-fetoprotein and prothrombin induced by vitamin K absence-II in serum, bile, and feces in hepatocellular carcinoma.

Diagnostic value of alpha-fetoprotein and prothrombin induced by vitamin K absence-II in serum, bile, and feces in hepatocellular carcinoma.

Journal: World journal of gastrointestinal oncology
Published: January 18, 2025

Dendritic Cell-Related Gene Signatures in Hepatocellular Carcinoma: An Analysis for Prognosis and Therapy Efficacy Evaluation.

Dendritic Cell-Related Gene Signatures in Hepatocellular Carcinoma: An Analysis for Prognosis and Therapy Efficacy Evaluation.

Journal: Journal of hepatocellular carcinoma
Published: June 04, 2024

Prognostic utility of gamma-glutamyl transpeptidase to platelet ratio in patients with solitary hepatitis B virus-related hepatocellular carcinoma after hepatectomy.

Prognostic utility of gamma-glutamyl transpeptidase to platelet ratio in patients with solitary hepatitis B virus-related hepatocellular carcinoma after hepatectomy.

Journal: World journal of gastrointestinal oncology
Published: February 28, 2024

Prognostic value of geriatric nutritional risk index and prognostic nutritional index in hepatocellular carcinoma.

Prognostic value of geriatric nutritional risk index and prognostic nutritional index in hepatocellular carcinoma.

Journal: Clinical nutrition ESPEN
Published: August 12, 2023

High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma.

High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma.

Journal: International journal of general medicine
Published: October 17, 2021

Oncogene UBE2I enhances cellular invasion, migration and proliferation abilities via autophagy-related pathway resulting in poor prognosis in hepatocellular carcinoma.

Oncogene UBE2I enhances cellular invasion, migration and proliferation abilities via autophagy-related pathway resulting in poor prognosis in hepatocellular carcinoma.

Journal: American journal of cancer research
Published: September 03, 2020

Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms.

Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms.

Journal: BMC gastroenterology
Published: July 23, 2020

Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma.

Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma.

Journal: Frontiers in oncology
Published: July 14, 2020

Clinical significance of long non-coding RNA DUXAP8 and its protein coding genes in hepatocellular carcinoma.

Clinical significance of long non-coding RNA DUXAP8 and its protein coding genes in hepatocellular carcinoma.

Journal: Journal of Cancer
Published: May 07, 2020

SOX4 as biomarker in hepatitis B virus-associated hepatocellular carcinoma.

SOX4 as biomarker in hepatitis B virus-associated hepatocellular carcinoma.

Journal: Journal of Cancer
Published: April 01, 2020

Genome-wide RNA-sequencing dataset reveals the prognostic value and potential molecular mechanisms of lncRNA in non-homologous end joining pathway 1 in early stage Pancreatic Ductal Adenocarcinoma.

Genome-wide RNA-sequencing dataset reveals the prognostic value and potential molecular mechanisms of lncRNA in non-homologous end joining pathway 1 in early stage Pancreatic Ductal Adenocarcinoma.

Journal: Journal of Cancer
Published: September 02, 2019

Novel candidate biomarkers of origin recognition complex 1, 5 and 6 for survival surveillance in patients with hepatocellular carcinoma.

Novel candidate biomarkers of origin recognition complex 1, 5 and 6 for survival surveillance in patients with hepatocellular carcinoma.

Journal: Journal of Cancer
Published: August 09, 2019
Showing 1-12 of 18

Last Updated: 09/26/2026